ALEXANDRIA CO. FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES

Alexandria Co. For Pharmaceuticals & Chemical Industries

AXPH

EGS38341C011

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 03:30:00 09/05/2024 am IST			5-day change	1st Jan Change
215.1 ^EGP	0.00%		0.00%	+20.65%

2023	Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023	CI
2022	Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022	CI

Alexandria Co. for Pharmaceuticals and Chemical Industries Recommends Cash Dividend for Fiscal Year 2019/2020

August 26, 2020

The board of directors of Alexandria Co. for Pharmaceuticals and Chemical Industries recommended a cash dividend distribution of EGP 11.5 per share for fiscal year 2019/2020.

Latest news about Alexandria Co. For Pharmaceuticals & Chemical Industries

Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023	15/11	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022	19/22/19	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2022	22/22/22	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2021	14/22/14	CI
VAlexandria Pharmaceuticals Announces Consolidated Earnings Results for the Six Months Ended December 31, 2020	16/21/16	CI
Alexandria Co. for Pharmaceuticals and Chemical Industries Recommends Cash Dividend for Fiscal Year 2019/2020	26/20/26	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Announces Earnings Results for the Year Ended on 30 June 2020	26/20/26	CI
Alexandria Pharmaceuticals Announces Earnings Results for the Year Ended June 30, 2019	29/19/29	CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2018	14/19/14	CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Reviewed Earnings Results for the Period Ended December 31, 2018	12/19/12	CI
Alexandria Pharmaceuticals Reports Earnings Results for the Three Months Ended September 30, 2018	13/18/13	CI
Alexandria Pharmaceuticals Declares Cash Dividend, Payable on October 28, 2018	09/18/09	CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended June 30, 2018	04/18/04	CI
Alexandria Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2018	13/18/13	CI
Alexandria Pharmaceuticals Reports Earnings Results for the Half Year Ended December 31, 2017	13/18/13	CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended September 30, 2017	12/17/12	CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended June 30, 2017	08/17/08	CI
Alexandria Pharmaceuticals Declares Cash Dividend, Payable on October 26, 2017	08/17/08	CI
Alexandria Pharmaceuticals Reports Audited Earnings Results for the Year Ended June 30, 2017	06/17/06	CI
Alexandria Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2017	14/17/14	CI
Alexandria Pharmaceuticals Reports Earning Results for the Six Months Ended December 31, 2016	13/17/13	CI
Alexandria Pharmaceuticals and Chemical Industries Co. Announces Earnings Results for the Quarter Ended September 2014	31/14/31	CI
Alexandria Pharmaceuticals and Chemical Industries Co. Announces Earnings Results for the Year Ended June 30, 2014	30/14/30	CI

Chart Alexandria Co. For Pharmaceuticals & Chemical Industries

Duration

Period

Chart Alexandria Co. For Pharmaceuticals & Chemical Industries

More charts

Alexandria Co. for Pharmaceuticals & Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, dermatological, cardiovascular, allergic, epileptic, gastrointestinal diseases, etc. The group also provides veterinary and medical products (adhesive tape, gauze compresses, gloves, traction kits, etc.).

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ALEXANDRIA CO. FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES	+20.65%	22.69M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals

Alexandria Co. For Pharmaceuticals & Chemical Industries

Equities

AXPH

EGS38341C011

Pharmaceuticals

Alexandria Co. for Pharmaceuticals and Chemical Industries Recommends Cash Dividend for Fiscal Year 2019/2020

Latest news about Alexandria Co. For Pharmaceuticals & Chemical Industries

Chart Alexandria Co. For Pharmaceuticals & Chemical Industries

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Pharmaceuticals